A-Alpha Bio

A-Alpha Bio

生物技术研究

Seattle,Washington 8,290 位关注者

The protein-protein interaction company

关于我们

A-Alpha Bio is a biotechnology company harnessing synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions. Our experimental platform, AlphaSeq, enables the rapid and quantitative measurement of millions of protein-protein binding affinities simultaneously. Our computational platform, AlphaBind, is trained on the world’s largest protein-protein interaction database and predicts binding strength from sequence. A-Alpha Bio leverages AlphaSeq and AlphaBind for in-house therapeutic programs and in partnership with leading pharmaceutical companies to inform the discovery and development of novel therapeutics. A-Alpha Bio is based in Seattle and was founded in 2017 at the University of Washington's Institute for Protein Design and Center for Synthetic Biology. To learn more, please visit: https://www.aalphabio.com/

网站
https://www.aalphabio.com/
所属行业
生物技术研究
规模
51-200 人
总部
Seattle,Washington
类型
私人持股
创立
2017
领域
Drug discovery、Protein Engineering、Synthetic Biology、Immunocytokines、Molecular Glues、Oncology和Protein-protein interactions

地点

  • 主要

    2101 4th Ave

    Fifth Floor

    US,Washington,Seattle,98121

    获取路线

A-Alpha Bio员工

动态

相似主页

查看职位

融资

A-Alpha Bio 共 9 轮

上一轮

补助

US$14,500,000.00

Crunchbase 上查看更多信息